Targeting ligands are molecules designed to bind specifically to certain receptors or antigens that are overexpressed on the surface of cancer cells. By selectively binding to these receptors, targeting ligands can direct therapeutic agents directly to the cancer cells, minimizing damage to healthy tissues.
